Secretion, blood levels and cutaneous expression of TL1A in psoriasis patients

Induction of IL-17+ T Cell Trafficking and Development by IFN- : Mechanism and Pathological Relevance in Psoriasis

(2014) I. Kryczek et al.   JOURNAL OF IMMUNOLOGY

TL1A Induces TCR Independent IL-6 and TNF-α Production and Growth of PLZF+ Leukocytes

(2014) Kirsten Reichwald et al.   PLoS One

Biomarkers in psoriasis and psoriatic arthritis

(2013) Federica Villanova et al.   ANNALS OF THE RHEUMATIC DISEASES

EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis

(2013) Nan-Lin Wu et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Genetic risk and protective factors of TNFSF15 gene variants detected using single nucleotide polymorphisms in Hungarians with psoriasis and psoriatic arthritis

(2013) László Képíró et al.   HUMAN IMMUNOLOGY

Antimicrobial peptides in the pathogenesis of psoriasis

(2012) Shin MORIZANE et al.   JOURNAL OF DERMATOLOGY

Upregulation and nuclear localization of TNF-like Cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions

(2011) Giorgos Bamias et al.   EXPERIMENTAL DERMATOLOGY

T cell exhaustion

(2011) E John Wherry   NATURE IMMUNOLOGY

TL1A in the inflammatory network in autoimmune diseases

(2010) Jagadeesh Bayry   Nature Reviews Rheumatology

Serum cytokines and growth factor levels in Japanese patients with psoriasis

(2009) H. Takahashi et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8

(2009) Dipyaman Ganguly et al.   JOURNAL OF EXPERIMENTAL MEDICINE

LL-37 Promotes Rapid Sensing of CpG Oligodeoxynucleotides by B Lymphocytes and Plasmacytoid Dendritic Cells

(2009) P. Hurtado et al.   JOURNAL OF IMMUNOLOGY

Psoriasis

(2009) Frank O. Nestle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis

(2008) Giorgos Bamias et al.   CLINICAL IMMUNOLOGY

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

(2008) Kim A Papp et al.   LANCET